These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 35484241)

  • 1. Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities.
    Li S; Stern AM
    Mol Psychiatry; 2022 Aug; 27(8):3182-3191. PubMed ID: 35484241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Aβ oligomers impair hippocampal LTP by disrupting glutamatergic/GABAergic balance.
    Lei M; Xu H; Li Z; Wang Z; O'Malley TT; Zhang D; Walsh DM; Xu P; Selkoe DJ; Li S
    Neurobiol Dis; 2016 Jan; 85():111-121. PubMed ID: 26525100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.
    Yang T; Li S; Xu H; Walsh DM; Selkoe DJ
    J Neurosci; 2017 Jan; 37(1):152-163. PubMed ID: 28053038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aβ oligomers from human brain impair mossy fiber LTP in CA3 of hippocampus, but activating cAMP-PKA and cGMP-PKG prevents this.
    Jin SX; Liu L; Li S; Meunier AL; Selkoe DJ
    Neurobiol Dis; 2022 Oct; 172():105816. PubMed ID: 35820646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMDA receptor regulation by amyloid-beta does not account for its inhibition of LTP in rat hippocampus.
    Raymond CR; Ireland DR; Abraham WC
    Brain Res; 2003 Apr; 968(2):263-72. PubMed ID: 12663096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CaMKII Metaplasticity Drives Aβ Oligomer-Mediated Synaptotoxicity.
    Opazo P; Viana da Silva S; Carta M; Breillat C; Coultrap SJ; Grillo-Bosch D; Sainlos M; Coussen F; Bayer KU; Mulle C; Choquet D
    Cell Rep; 2018 Jun; 23(11):3137-3145. PubMed ID: 29898386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer's brain.
    Li S; Selkoe DJ
    J Neurochem; 2020 Sep; 154(6):583-597. PubMed ID: 32180217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent.
    Puzzo D; Piacentini R; Fá M; Gulisano W; Li Puma DD; Staniszewski A; Zhang H; Tropea MR; Cocco S; Palmeri A; Fraser P; D'Adamio L; Grassi C; Arancio O
    Elife; 2017 Jul; 6():. PubMed ID: 28696204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing the Receptor Tyrosine Kinase EphB2 Prevents Amyloid-β-induced Depletion of Cell Surface Glutamate Receptors by a Mechanism That Requires the PDZ-binding Motif of EphB2 and Neuronal Activity.
    Miyamoto T; Kim D; Knox JA; Johnson E; Mucke L
    J Biol Chem; 2016 Jan; 291(4):1719-1734. PubMed ID: 26589795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
    Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
    J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo.
    Klyubin I; Ondrejcak T; Hayes J; Cullen WK; Mably AJ; Walsh DM; Rowan MJ
    Philos Trans R Soc Lond B Biol Sci; 2014 Jan; 369(1633):20130147. PubMed ID: 24298149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytic N-Methyl-D-Aspartate Receptors Protect the Hippocampal Neurons Against Amyloid-β142-Induced Synaptotoxicity by Regulating Nerve Growth Factor.
    Song Y; Du Z; Chen X; Zhang W; Zhang G; Li H; Chang L; Wu Y
    J Alzheimers Dis; 2022; 85(1):167-178. PubMed ID: 34776441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabotropic Glutamate Receptors in Alzheimer's Disease Synaptic Dysfunction: Therapeutic Opportunities and Hope for the Future.
    Srivastava A; Das B; Yao AY; Yan R
    J Alzheimers Dis; 2020; 78(4):1345-1361. PubMed ID: 33325389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.
    Danysz W; Parsons CG
    Br J Pharmacol; 2012 Sep; 167(2):324-52. PubMed ID: 22646481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease amyloid beta-protein and synaptic function.
    Ondrejcak T; Klyubin I; Hu NW; Barry AE; Cullen WK; Rowan MJ
    Neuromolecular Med; 2010 Mar; 12(1):13-26. PubMed ID: 19757208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytic glutamatergic transporters are involved in Aβ-induced synaptic dysfunction.
    Huang S; Tong H; Lei M; Zhou M; Guo W; Li G; Tang X; Li Z; Mo M; Zhang X; Chen X; Cen L; Wei L; Xiao Y; Li K; Huang Q; Yang X; Liu W; Zhang L; Qu S; Li S; Xu P
    Brain Res; 2018 Jan; 1678():129-137. PubMed ID: 29066369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease.
    Tu S; Okamoto S; Lipton SA; Xu H
    Mol Neurodegener; 2014 Nov; 9():48. PubMed ID: 25394486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Aβ oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors.
    Li S; Jin M; Koeglsperger T; Shepardson NE; Shankar GM; Selkoe DJ
    J Neurosci; 2011 May; 31(18):6627-38. PubMed ID: 21543591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.